rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
20
|
pubmed:dateCreated |
2009-7-9
|
pubmed:abstractText |
Circulating tumor cells (CTCs) and [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) are two new promising tools for therapeutic monitoring. In this study, we compared the prognostic value of CTC and FDG-PET/CT monitoring during systemic therapy for metastatic breast cancer (MBC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:AndreopoulouEleniE,
pubmed-author:CristofanilliMassimoM,
pubmed-author:DawoodShaheenahS,
pubmed-author:De GiorgiUgoU,
pubmed-author:DoyleGerald VGV,
pubmed-author:FritscheHerbert AHA,
pubmed-author:HandyBeverly CBC,
pubmed-author:HortobagyiGabriel NGN,
pubmed-author:JacksonSummerS,
pubmed-author:MacapinlacHomer AHA,
pubmed-author:MillerM CraigMC,
pubmed-author:ReubenJames MJM,
pubmed-author:RohrenEricE,
pubmed-author:UenoNaoto TNT,
pubmed-author:ValeroVicenteV
|
pubmed:issnType |
Electronic
|
pubmed:day |
10
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3303-11
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19451443-Aged,
pubmed-meshheading:19451443-Breast Neoplasms,
pubmed-meshheading:19451443-Female,
pubmed-meshheading:19451443-Fluorodeoxyglucose F18,
pubmed-meshheading:19451443-Humans,
pubmed-meshheading:19451443-Kaplan-Meier Estimate,
pubmed-meshheading:19451443-Middle Aged,
pubmed-meshheading:19451443-Multivariate Analysis,
pubmed-meshheading:19451443-Neoplasm Metastasis,
pubmed-meshheading:19451443-Neoplastic Cells, Circulating,
pubmed-meshheading:19451443-Positron-Emission Tomography,
pubmed-meshheading:19451443-Prognosis,
pubmed-meshheading:19451443-Proportional Hazards Models,
pubmed-meshheading:19451443-Retrospective Studies,
pubmed-meshheading:19451443-Survival Rate,
pubmed-meshheading:19451443-Tomography, X-Ray Computed,
pubmed-meshheading:19451443-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
|
pubmed:affiliation |
The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|